NYC Landmark Goes Pink: United Breast Cancer Foundation's Times Square Display Features Early Detection
1 in 8 Women will face breast cancer, but thanks to UBCF, they can have a fighting chance HUNTINGTON, N.Y., Feb. 15, 2024 /PRNewswire-PRWeb/ -- The Nasdaq Tower in Times Square shines a different kind of light in February: a beacon of hope and support for those facing breast cancer.... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 15, 2024 Category: Pharmaceuticals Tags: NPT Source Type: news
No Change in Huntington's Motor Symptoms With Investigational Drug
(MedPage Today) -- Investigational laquinimod did not change motor symptoms of Huntington's disease after 1 year but did significantly reduce caudate volume loss compared with placebo, the phase II LEGATO-HD trial found.
At week 52, mean change... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - February 8, 2024 Category: Neurology Source Type: news
Clever Care Health Plan Grows 112% YOY In Southern California Through Commitment To Health Equity
A culturally inclusive health plan, now at over 22,000 members, continues to resonate with the underserved senior population. HUNTINGTON BEACH, Calif., Jan. 23, 2024 /PRNewswire-PRWeb/ -- In 2021, Clever Care Health Plan Inc. ("Clever Care") went to market with a Medicare Advantage Plan... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 23, 2024 Category: Pharmaceuticals Source Type: news
Glen Powell Finds Next Star Vehicle In Thriller ‘Huntington’ Inspired By Brit Classic ‘Kind Hearts And Coronets’; Studiocanal & Participant Aboard With A24 …
With Anyone But You having just crossed $100M at the global box office and Top Gun 3 chatter lighting up the internet, Hollywood man of the moment Glen Powell has found his next project in the shape of thriller Huntington from Emily The Criminal writer-director John Patton Ford. As we revealed…#hollywood #glenpowell #johnpattonford #euro #studiocanal #missouri #greenbook #a24 #becketredfellow #pattonfords (Source: Reuters: Health)
Source: Reuters: Health - January 22, 2024 Category: Consumer Health News Source Type: news
Home remodel: Expert offers tips on choosing the perfect faucet
Every home has at least one. But how many people know what goes into making and — more important — choosing a bathroom faucet? Curious, I called Noah Taft, co-owner of Huntington Beach-based California Faucets, which makes high-end faucets. Together we plumbed the topic. Taft started out in…#noahtaft #huntingtonbeach #californiafaucets #hollywood #afirst #pvd #satinnickel #marnijameson #rightsizetoday (Source: Reuters: Health)
Source: Reuters: Health - January 11, 2024 Category: Consumer Health News Source Type: news
Vico Therapeutics Announces $60 million (54 million) Series B Financing to Advance VO659 Clinical-Stage Program for Rare Neurological Diseases and Expand Pipeline
Funding supports ongoing Phase 1/2a clinical trial evaluating VO659 in patients with spinocerebellar ataxia type 3 and type 1 and Huntington's disease
Financing led by Ackermans & van Haaren along with Droia Ventures, EQT Life Sciences and Kurma Partner... Biopharmaceuticals, Neurology, Venture Capital Vico Therapeutics, spinocerebellar ataxia, Huntington's disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 5, 2024 Category: Pharmaceuticals Source Type: news
Major breakthrough unveils immune system & #039;s guardian: IKAROS
In a scientific breakthrough that aids our understanding of the internal wiring of immune cells, researchers at Monash University in Australia have cracked the code behind IKAROS, an essential protein for immune cell development and protection against pathogens and cancer.
This disruptive research, led by the eminent Professor Nicholas Huntington of Monash University's Biomedicine Discovery Institute, is poised to reshape our comprehension of gene control networks and its impact on everything from eye colour to cancer susceptibility and design of novel therapies. (Source: World Pharma News)
Source: World Pharma News - January 5, 2024 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Novartis, Voyager sign gene therapy deal worth up to $1.3B
The companies have agreed to a collaboration and license agreement to develop gene therapies for Huntington ’s disease and spinal muscular atrophy. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 2, 2024 Category: Biotechnology Authors: Hannah Green Source Type: news
Why Is Gene Therapy Focused Voyager Therapeutics Stock Soaring Today?
Voyager Therapeutics Inc VYGR announced a strategic collaboration and capsid license agreement with Novartis Pharma AG, a subsidiary of Novartis AG NVS, to advance potential gene therapies for Huntington's disease (HD) and spinal muscular atrophy (SMA). Voyager will provide Novartis a…#novartispharmaag #novartisagnvs #sma #voyager #novartis #voyagertracer #alfredsandrock #tracer #aav (Source: Reuters: Health)
Source: Reuters: Health - January 2, 2024 Category: Consumer Health News Source Type: news
This Biotech Just Catapulted 28%, Flashing A Bullish Sign
expanded its gene therapy collaboration with Voyager Therapeutics (VYGR) on Monday. VYGR stock rocketed above its 200-day line for the first time in four months. The two companies will work together to test gene therapies for Huntington's disease and spinal muscular atrophy. Both inherited…#voyagertherapeutics #huntington #voyager #vygr #marketsmithcom #allisongatlin #ibdagatlin #creamofcrop #3steps #avoidbiglosses (Source: Reuters: Health)
Source: Reuters: Health - January 2, 2024 Category: Consumer Health News Source Type: news
Voyager Therapeutics shares jump after $1.2 billion deal with Novartis
Voyager Therapeutics said on Tuesday Novartis would pay $100 million upfront as part of a licensing deal to develop gene therapy candidates. Voyager, whose shares jumped 35% in premarket trading, would provide Novartis a target-exclusive license to access its RNA-based screening platform and…#voyagertherapeutics #voyager #novartis #rna #huntington (Source: Reuters: Health)
Source: Reuters: Health - January 2, 2024 Category: Consumer Health News Source Type: news
Researcher loses disability lawsuit against major science funder
A jury in Maryland today delivered a unanimous verdict in favor of the Howard Hughes Medical Institute (HHMI), finding it did not discriminate against Vivian Cheung, a disabled biologist and physician, when it failed to renew her multimillion-dollar award in 2018. The closely watched case put a spotlight on obstacles faced by disabled scientists.
Lawyer Chong Park of Ropes & Gray was successful in persuading a jury of four women and two men that HHMI and its reviewers treated Cheung like any other scientist when she competed unsuccessfully to renew her investigator award for RNA studies. At the end of an 8-day tr...
Source: ScienceNOW - December 14, 2023 Category: Science Source Type: news
Antisense Drug Trial Provides Key Insights About Huntington's Disease
(MedPage Today) -- The halted GENERATION HD1 (GENHD1) study of the investigational antisense drug tominersen provided insights about Huntington's disease staging and informed future clinical trials, researchers said.
The phase III study involved... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - December 7, 2023 Category: Neurology Source Type: news
When your world feels out of control, can forest therapy help?
The world feels apocalyptic. I saw a Forest Therapist at — of all places — the Huntington Library, Art Museum and Botanical Gardens. It helped. (Source: L.A. Times - Health)
Source: L.A. Times - Health - November 29, 2023 Category: Consumer Health News Authors: Deborah Vankin Source Type: news
Forest Therapy may be your unexpected stress reliever
The world feels apocalyptic. I saw a Forest Therapist at — of all places — the Huntington Library, Art Museum and Botanical Gardens. It helped. (Source: L.A. Times - Health)
Source: L.A. Times - Health - November 29, 2023 Category: Consumer Health News Authors: Deborah Vankin Source Type: news
